Target intelligence / Profile preview

Pathogenic microflora

Molecular classification
Other
01

Overview

Pathogenic microflora refers to the collective group of microorganisms, including bacteria, fungi, viruses, and parasites, that are capable of causing infectious diseases in a host organism [1]. This term is not a single molecular target like an enzyme or receptor; rather, it represents a diverse biological category of entities that disrupt host homeostasis through mechanisms such as toxin production, tissue invasion, and immune evasion [2]. In clinical pharmacology, drugs are designed to target specific molecular components within these organisms—such as the bacterial ribosome, cell wall synthesis enzymes, or fungal ergosterol—to inhibit growth or induce cell death [3]. A major challenge in addressing pathogenic microflora is the emergence of antimicrobial resistance (AMR), which renders standard treatments ineffective [4]. Furthermore, broad-spectrum therapeutic interventions often result in dysbiosis, the harmful disruption of the host's commensal microbiome [5]. References: [1] National Institute of Allergy and Infectious Diseases (NIAID); [2] StatPearls, 'Infection Control'; [3] Merck Manuals, 'Overview of Antibacterial Drugs'; [4] World Health Organization (WHO), 'Antimicrobial Resistance'; [5] Nature Reviews Microbiology, 'The Human Microbiome and Infectious Diseases'.

Other names
Pathogenic microorganismsPathogensInfectious agentsPathogenic bacteriaPathogenic fungiPathogenic protozoaGerms
02

Mechanism of action

Inhibition of cell wall synthesis, inhibition of protein synthesis (ribosomal targeting), inhibition of nucleic acid synthesis, disruption of cell membrane integrity, and inhibition of essential metabolic pathways.

03

Biological functions

PathogenesisHost-pathogen interactionBiofilm formationToxin productionCellular invasionImmune evasion
04

Disease associations

InfectionSepsisInflammationAbscessBacteremia
05

Safety considerations

Antimicrobial resistance (AMR)Dysbiosis (destruction of beneficial commensal microbiota)Systemic toxicityHypersensitivity reactionsJarisch-Herxheimer reaction
06

Interacting drugs

Penicillin

6 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Procalcitonin (PCT)Pathogen-specific DNA/RNA (PCR detection)Microbial cultureGram stain

Beyond the preview

Go deeper on Pathogenic microflora.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic microflora.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call